Ommen Sara J, Mithra Prasanna, T Rekha, Kumar Nithin, Holla Ramesh, Kulal Naveen, Rao Mithun, Unnikrishnan Bhaskaran
Department of Community Medicine, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
District Vector Borne Disease Control Programme Office, Dakshina Kannada, Mangalore, Karnataka, India.
BMC Infect Dis. 2025 Jul 19;25(1):927. doi: 10.1186/s12879-025-11324-4.
Post-Coronavirus Disease-19 (COVID-19) sequelae involve complex biological processes that can alter the progression and clinical outcome of other infectious diseases. However, there is no documented information on the influence of COVID-19 on the development of severe malaria and dengue. Hence, this study was conducted to determine the association between malaria & dengue and previous COVID-19 infection among the adult population of Mangalore Taluk and to describe the socio-demographic and clinical correlates of malaria & dengue.
This case-control study was conducted among 293 participants who were positive for either malaria or dengue from November 2022 to August 2024. Data were collected using a proforma which contained sections on demographic details, clinical profile and comorbidities, history of COVID-19 infection and COVID-19 vaccination status. The participants were categorised into having severe disease and mild to moderate disease based on operational definitions. The data were analysed using the Statistical Package for Social Sciences (SPSS) version 29. Chi-square test was done, and a p-value less than 0.05 was considered statistically significant. Binary Logistic Regression analyses were used and odds ratios were estimated.
A total of 293 participants were included in the study with a mean age of 36.7 (SD:14.8) years. Among them, 23.9% (n = 70) had malaria and 76.1% (n = 223) had dengue. Out of those who had malaria, 30% (n = 21) developed severe illness, whereas among those who had dengue 35.8% (n = 80) developed severe dengue. Overall, 58.4% (n = 171) were in the age group of > 30 years. In total, 98.1% (n = 52) of the participants with dengue fever with a history of COVID-19 infection developed severe dengue, (aOR:55.93 (95% CI:7.17-435.92) p < 0.001) compared to those without. Similarly, 85.7% (n = 12) of the participants with a history of COVID-19 infection developed severe malaria (aOR: 263.7 (95% CI: 34.9-1987.4) p < 0.001) compared to those and these differences were found to be statistically significant. In addition, those participants belonging to lower socio-economic classes had higher chances of developing severe dengue than those belonging to the upper socio-economic class (p < 0.001*).
Those with a prior history of COVID-19 infection had higher chances of developing severe malaria and dengue than those without a history of COVID-19 infection.
新型冠状病毒肺炎(COVID-19)后遗症涉及复杂的生物学过程,可改变其他传染病的进展和临床结局。然而,关于COVID-19对重症疟疾和登革热发展的影响,尚无文献记载。因此,本研究旨在确定芒格洛尔 Taluk 成年人群中疟疾和登革热与既往COVID-19感染之间的关联,并描述疟疾和登革热的社会人口学及临床相关因素。
本病例对照研究在2022年11月至2024年8月期间对293名疟疾或登革热检测呈阳性的参与者进行。使用一份包含人口统计学细节、临床特征和合并症、COVID-19感染史及COVID-19疫苗接种状况等部分的表格收集数据。根据操作定义,将参与者分为患有严重疾病和轻度至中度疾病两类。使用社会科学统计软件包(SPSS)29版进行数据分析。进行卡方检验,p值小于0.05被认为具有统计学意义。采用二元逻辑回归分析并估计比值比。
共有293名参与者纳入研究,平均年龄为36.7(标准差:14.8)岁。其中,23.9%(n = 70)患有疟疾,76.1%(n = 223)患有登革热。在患疟疾的人群中,30%(n = 21)发展为重症,而在患登革热的人群中,35.8%(n = 80)发展为重症登革热。总体而言,58.4%(n = 171)属于年龄大于30岁的年龄组。与无COVID-19感染史的登革热患者相比,有COVID-19感染史的登革热患者中98.1%(n = 52)发展为重症登革热,(调整后比值比:55.93(95%置信区间:7.17 - 435.92),p < 0.001)。同样,与无COVID-19感染史的患者相比,有COVID-19感染史的参与者中85.7%(n = 12)发展为重症疟疾(调整后比值比:263.7(95%置信区间:34.9 - 1987.4),p < 0.001),且这些差异具有统计学意义。此外,社会经济地位较低的参与者比社会经济地位较高的参与者患重症登革热的几率更高(p < 0.001*)。
与无COVID-19感染史的人相比,有COVID-19感染史的人患重症疟疾和登革热的几率更高。